| Jun 3 |
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
|
| Jun 3 |
GSK stock sinks after court allows Zantac lawsuits to proceed
|
| Jun 3 |
Biggest stock movers today: Meme stocks, GSK, SRCL, and more
|
| Jun 3 |
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
|
| Jun 3 |
GSK stock plunges after 75,000 Zantac cases allowed to move forward
|
| Jun 2 |
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
|
| Jun 1 |
GSK, Pfizer must face tens of thousands of Zantac cases in Delaware
|
| May 31 |
Moderna Looks for Boost From Newly Approved RSV Shot
|
| May 30 |
Third human bird flu case found in U.S.
|
| May 28 |
GSK plc: Long-Term Cash Cow
|
